Effectiveness of a Virtual Tobacco Treatment for Cancer Patients

Effectiveness of a Virtual Tobacco Treatment for Cancer Patients

Author: American Society of Clinical Oncology (ASCO) July 16, 2026 Duration: 24:21

Guests Dr. Elise Park, Dr. Jamie Ostrov and host Dr. Davide Soldato discuss JCO article "Virtual Sustained Tobacco Treatment for Cancer Patients: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) within the NCI Community Oncology Research Program (NCORP)" and their groundbreaking trial on virtual tobacco cessation treatment for cancer patients in community settings.

LINK TO FULL TRANSCRIPT


Hosted by Dr. Davide Soldato, the Journal of Clinical Oncology (JCO) Podcast from the American Society of Clinical Oncology (ASCO) transforms pivotal research into accessible conversation. Each episode focuses directly on a significant study or theme from the latest issue of the Journal of Clinical Oncology, moving from the printed page into a dynamic analysis of what the findings truly mean. Listeners are brought into a detailed scholarly discourse that unpacks methodology, contextualizes results, and debates implications for real-world patient care. This isn't just a summary; it's a critical examination designed for practicing oncologists, fellows, and dedicated healthcare professionals who need to integrate cutting-edge evidence into their daily decisions. The podcast regularly features interviews and in-depth summaries led by the journal's annual fellows, adding fresh, trainee-led perspectives on complex oncology topics. By focusing on the most urgent and practice-changing publications, this podcast serves as an essential audio companion for anyone committed to understanding the rapid evolution of cancer treatment. It’s where rigorous science meets clinical reality, helping the oncology community navigate a constant stream of advancements through informed discussion and expert insight.
Author: Language: English Episodes: 50

Journal of Clinical Oncology (JCO) Podcast
Podcast Episodes
JCO at 2025 ASH: Pirtobrutinib in Untreated CLL [not-audio_url] [/not-audio_url]

Duration: 20:17
JCO Editor-in-Chief Dr. Jonathan Friedberg is joined by colleagues Dr. Jennifer Woyach, Dr. Wojciech Jurczak, and Dr. Matthew Davids to discuss simultaneous publications presented at ASH 2025 on pertibrutinib, a new upfr…
Health Outcomes in Older Childhood Cancer Survivors [not-audio_url] [/not-audio_url]

Duration: 21:22
Guest Dr. Rusha Bhandari and host Dr. Davide Soldato discuss JCO article "Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study, " with a particular focus…
Long-Term Remission After Cilta-cel in Patients With RRMM [not-audio_url] [/not-audio_url]

Duration: 27:31
Guest Dr. Sundar Jagannath and host Dr. Davide Soldato discuss JCO article "Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multi…
Income Among Adolescents and Young Adults Surviving Cancer [not-audio_url] [/not-audio_url]

Duration: 16:16
Host Dr. Shannon Westin and guest Dr. Giancarlo Di Guiseppe discuss the JCO article "Long-Term Dynamic Financial Impacts Among Adolescents and Young Adults With Cancer: A Longitudinal Matched-Cohort Study" TRANSCRIPT The…
TTFields in Locally Advanced Pancreatic Adenocarcinoma [not-audio_url] [/not-audio_url]

Duration: 18:42
Host Dr. Shannon Westin and guest Dr. Hani Babiker discuss the JCO article "Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase…